{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:15:06Z","timestamp":1791400506313,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.07.031","type":"journal-article","created":{"date-parts":[[2006,8,3]],"date-time":"2006-08-03T12:29:21Z","timestamp":1154608161000},"page":"314-326","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent"],"prefix":"10.1016","volume":"25","author":[{"given":"Katharina H.","family":"T\u00f6pfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard K.","family":"Straubinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.vaccine.2006.07.031_bib1","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1017\/S0031182003004694","article-title":"Lyme borreliosis in Europe and North America","volume":"129","author":"Piesman","year":"2004","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/esm.10.04.00531-en","article-title":"Surveillance of Lyme borreliosis in Germany, 2002 and 2003","volume":"10","author":"Mehnert","year":"2005","journal-title":"Euro Surveill"},{"issue":"11","key":"10.1016\/j.vaccine.2006.07.031_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2460\/javma.1993.202.11.1834","article-title":"Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas","volume":"202","author":"Levy","year":"1993","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2460\/javma.1992.201.03.412","article-title":"Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb\/joint dysfunction in dogs with borreliosis","volume":"201","author":"Wasmoen","year":"1992","journal-title":"J Am Vet Med Assoc"},{"issue":"4980","key":"10.1016\/j.vaccine.2006.07.031_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.031_bib6","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.87.10.3768","article-title":"Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice","volume":"87","author":"Schaible","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.031_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF01716093","article-title":"The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine","volume":"24","author":"Wallich","year":"1996","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/infdis\/171.4.1049","article-title":"Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21","volume":"171","author":"Coughlin","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/IAI.73.3.1644-1647.2005","article-title":"Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks","volume":"73","author":"Gipson","year":"2005","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant outer-surface protein A Lyme disease vaccine study consortium","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.031_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14760584.2.5.683","article-title":"Progress and controversy surrounding vaccines against Lyme disease","volume":"2","author":"Hanson","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.031_bib13","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1086\/317479","article-title":"Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2\u20135 years old","volume":"31","author":"Beran","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.031_bib14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.271.22.1764","article-title":"Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine","volume":"271","author":"Keller","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0149-2918(00)80035-1","article-title":"Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1 and 2 months","volume":"22","author":"Schoen","year":"2000","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2006.07.031_bib16","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/IAI.63.9.3543-3549.1995","article-title":"Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi","volume":"63","author":"Chang","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2460\/javma.1992.201.03.403","article-title":"Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin","volume":"201","author":"Chu","year":"1992","journal-title":"J Am Vet Med Assoc"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.031_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/JCM.33.10.2745-2751.1995","article-title":"Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi","volume":"33","author":"Straubinger","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.07.031_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(01)00251-1","article-title":"Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine","volume":"20","author":"Straubinger","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2006.07.031_bib20","first-page":"874","article-title":"Clinical manifestation, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs","volume":"110","author":"Straubinger","year":"1998","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"10.1016\/j.vaccine.2006.07.031_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0264-410X(91)90236-Y","article-title":"Perspective on the development of vaccines against Lyme disease","volume":"9","author":"Edelman","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.031_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-110-7-501","article-title":"The diagnosis of Lyme disease: rewards and perils","volume":"110","author":"Barbour","year":"1989","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.031_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/01652176.1999.9694992","article-title":"Presence and distribution of Borrelia burgdorferi sensu lato species in internal organs and skin of naturally infected symptomatic and asymptomatic dogs, as detected by polymerase chain reaction","volume":"21","author":"Hovius","year":"1999","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2006.07.031_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.me.43.020192.000521","article-title":"Complications of Lyme disease","volume":"43","author":"Cooke","year":"1992","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.031_bib25","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/345284","article-title":"Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment","volume":"186","author":"Bockenstedt","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/315340","article-title":"Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study","volume":"181","author":"Straubinger","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.031_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/514779","article-title":"Alternative vaccination schedules (0, 1 and 6 months versus 0, 1 and 12 months) for a recombinant OspA Lyme disease vaccine","volume":"28","author":"Van Hoecke","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI9427","article-title":"Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A","volume":"106","author":"Pal","year":"2000","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2006.07.031_bib29","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.166.12.7398","article-title":"Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody","volume":"166","author":"Pal","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.031_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1073\/pnas.98.2.670","article-title":"Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks","volume":"98","author":"Ohnishi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2006.07.031_bib31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1099\/00207713-42-3-378","article-title":"Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme disease","volume":"42","author":"Baranton","year":"1992","journal-title":"Int J Syst Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1128\/JCM.42.3.1316-1318.2004","article-title":"First isolation of Borrelia lusitaniae from a human patient","volume":"42","author":"Collares-Pereira","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.031_bib33","first-page":"521","article-title":"Isolation and cultivation of Lyme disease spirochetes","volume":"57","author":"Barbour","year":"1984","journal-title":"Yale J Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.07.031_bib34","first-page":"112","article-title":"European Borrelia burgdorferi isolated from humans and ticks\u2014culture conditions and antibiotic susceptibility","volume":"263","author":"Preac-Mursic","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"key":"10.1016\/j.vaccine.2006.07.031_bib35","series-title":"Molecular cloning. A laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2006.07.031_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-1135(93)90137-V","article-title":"Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs","volume":"36","author":"Shin","year":"1993","journal-title":"Vet Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.07.031_bib37","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2460\/javma.1995.207.11.1435","article-title":"Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection","volume":"207","author":"Barthold","year":"1995","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1096-2867(96)80030-2","article-title":"Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs","volume":"11","author":"Jacobson","year":"1996","journal-title":"Semin Vet Med Surg Small Anim"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.031_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.20506\/rst.17.2.1119","article-title":"Validation of serological assays for diagnosis of infectious diseases","volume":"17","author":"Jacobson","year":"1998","journal-title":"Rev Sci Tech OIE"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2460\/javma.1992.200.03.344","article-title":"Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb\/joint borreliosis","volume":"200","author":"Levy","year":"1992","journal-title":"J Am Vet Med Assoc"},{"issue":"7","key":"10.1016\/j.vaccine.2006.07.031_bib41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/323392","article-title":"Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans","volume":"184","author":"Philipp","year":"2001","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2006.07.031_bib42","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1469-0691.2004.01026.x","article-title":"Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy","volume":"10","author":"Cinco","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"10.1016\/j.vaccine.2006.07.031_bib43","first-page":"650","article-title":"The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests","volume":"128","author":"Goossens","year":"2003","journal-title":"Tijdschr Diergeneeskd"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.031_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/104063879901100309","article-title":"Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs","volume":"11","author":"Gauthier","year":"1999","journal-title":"J Vet Diagn Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.031_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/JCM.35.1.169-173.1997","article-title":"Serologic diagnosis of canine and equine borreliosis: use of recombinant antigens in enzyme-linked immunosorbent assays","volume":"35","author":"Magnarelli","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.031_bib46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1099\/0022-1317-50-10-889","article-title":"Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis","volume":"50","author":"Magnarelli","year":"2001","journal-title":"J Med Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.07.031_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-1135(93)90137-V","article-title":"Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs","volume":"36","author":"Shin","year":"1993","journal-title":"Vet Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.031_bib48","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JCM.35.6.1433-1444.1997","article-title":"Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato","volume":"35","author":"Hauser","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.031_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/153036602321653833","article-title":"Diversity of Ixodes-borne Borrelia species\u2014clinical, pathogenetic, and diagnostic implications and impact on vaccine development","volume":"2","author":"Van Dam","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2006.07.031_bib50","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0264-410X(97)00066-2","article-title":"Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii","volume":"15","author":"Gern","year":"1997","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T21:14:23Z","timestamp":1707167663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06008991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06008991"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}